1 not yet recruiting, 1 terminated, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Piracetam: new trials by email Literature Review of Piracetam trials Research Report on Piracetam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Piracetam on Diabetic Peripheral Neuropathy Patients Piracetam, Placebo - Diabetic Peripheral Neuropathy | Phase 4 | Not yet recruiting | Ain Shams University | 60 | 2025-02-10 | 2025-01-28 |
| Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker Piracetam - Drug Adherence Marker | Phase 4 | Unknown | The Netherlands Cancer Institute | 10 | 2023-07-03 | 2023-06-26 |
| A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke Piracetam, Placebo - Acute Ischaemic Middle Cerebral Artery Stroke | Phase 4 | Terminated | UCB S.A. - Pharma Sector | 571 | 1998-08-01 | 2013-08-30 |
Aphasia (1) · Diabetes Mellitus (1) · Ischemia (1) · Medication Adherence (1) · Peripheral Nervous System Diseases (1) · Stroke (1)
Ain Shams University (1) · The Netherlands Cancer Institute (1) · UCB S.A. - Pharma Sector (1)
Argentina (1) · Austria (1) · Belgium (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Norway (1) · Poland (1) · Singapore (1) · Spain (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1)